Lifecore Biomedical Inc.

NASDAQ: LFCR · Real-Time Price · USD
7.39
-0.03 (-0.40%)
At close: Aug 15, 2025, 2:59 PM

Lifecore Biomedical Income Statement

Financials in USD. Fiscal year is June - May.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 25, 2025 Feb 23, 2025 Nov 24, 2024 Aug 25, 2024 May 26, 2024 Feb 25, 2024 Nov 26, 2023 Aug 27, 2023 May 28, 2023 Feb 26, 2023 Nov 27, 2022 Aug 28, 2022 May 29, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020
Revenue
36.44M 35.15M 32.56M 24.7M 37.89M 35.7M 30.15M 24.52M 31.55M 26.54M 21.86M 43.35M 47.63M 53.07M 129.49M 128.79M 139.83M 137.78M 130.9M 135.64M
Cost of Revenue
22.46M 25.31M 21.48M 19.32M 20.61M 23.81M 20.19M 21.79M 23.16M 17.99M 16.18M 37.1M 36.12M 39.18M 116.5M 111.27M 115.03M 118.09M 110.27M 119.3M
Gross Profit
13.98M 9.85M 11.08M 5.39M 17.27M 11.89M 9.96M 2.73M 8.39M 8.55M 5.68M 6.25M 11.51M 13.89M 12.99M 17.52M 24.8M 19.69M 20.64M 16.35M
Operating Income
2.9M -9.03M -1.96M -11.58M 2.15M -124K -1.33M -8.62M -5.03M -6.53M -5.35M -6.46M -5.97M -3.75M -3.46M -3.81M 1.23M -793K -1.47M -12.47M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a 15K 22K 16K 15K 15K 20K 19K 27K 17K 13K 10K 8K
Pretax Income
-1.11M -14.78M -6.53M -16.25M -7.14M 15M 14.18M -12.52M -33.57M -11.26M -9.2M -11.35M -36.4M -7.38M -41.27M -11.59M -3.44M -5.71M -16M -15.31M
Net Income
-1.15M -14.77M -6.57M -16.23M -7.08M 15.63M 14.22M -10.75M -36.13M -36.51M -12.81M -11.35M -36.47M -12.85M -38.44M -9.48M -2.87M -5.5M -13.3M -11M
Selling & General & Admin
8.98M 10.09M 11.12M 14.3M 12.22M 9.85M 9.19M 9.21M 11.69M 10.28M 10.77M 10.66M 15.42M 9.72M 13.84M 15.94M 16.14M 15.22M 16.11M 17.9M
Research & Development
2.1M 2.04M 1.92M 2.19M 2.16M 2.17M 2.1M 2.15M 2.12M 2.23M 2.12M 2.05M 2.06M 2.06M 2.72M 2.83M 2.58M 2.56M 2.57M 2.51M
Other Expenses
n/a 6.74M n/a 483K n/a n/a n/a n/a n/a 2.57M n/a n/a n/a n/a 79K 109K 46K 72K n/a -21K
Operating Expenses
11.08M 18.87M 13.04M 16.97M 14.38M 12.02M 11.28M 11.35M 13.8M 15.08M 10.47M 12.71M 17.48M 11.78M 16.55M 18.77M 18.71M 17.78M 18.68M 20.41M
Interest Expense
5.52M 5.48M 5.46M 5.37M 5.79M 4.29M 4.07M 3.94M 3.93M 4.83M 3.61M 3.68M 3.48M 4.11M 3.09M 6.68M 5.02M 2.94M 3.04M 3.11M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 5.1K n/a n/a n/a 5.6K n/a n/a n/a 100K n/a n/a n/a
Cost & Expenses
33.55M 44.18M 34.52M 36.29M 35.74M 36.6M 31.48M 33.15M 36.96M 33.07M 26.65M 49.81M 53.6M 50.96M 133.05M 130.03M 133.75M 135.88M 128.94M 139.71M
Income Tax Expense
33K -8K 43K -25K -57K 217K -65K 88K 223K 70K 4K 4K -518K -276K -2.82M -2.11M -575K -217K -2.7M -4.31M
Shares Outstanding (Basic)
37.03M 37.02M 34.36M 30.86M 30.56M 30.49M 30.46M 30.4M 30.32M 30.3M 30.3M 29.58M 29.51M 28.86M 29.47M 29.36M 29.33M 29.3M 28.34M 28.95M
Shares Outstanding (Diluted)
37.03M 37.02M 34.36M 30.86M 30.56M 36.61M 36.42M 30.4M 30.32M 30.3M 30.3M 29.58M 29.51M 29.48M 29.47M 29.42M 29.33M 29.32M 29.28M 29.24M
EPS (Basic)
-0.06 -0.47 -0.25 -0.53 -0.23 0.51 0.47 -0.35 -1.19 -1.2 -0.42 -0.38 -1.24 -0.45 -1.3 -0.32 -0.1 -0.19 -0.47 -0.38
EPS (Diluted)
-0.06 -0.47 -0.25 -0.53 -0.23 0.43 0.39 -0.35 -1.19 -1.2 -0.42 -0.38 -1.24 -0.44 -1.3 -0.32 -0.1 -0.19 -0.45 -0.38
EBITDA
6.32M -7.22M 981K -8.89M 4.64M 21.3M 20.02M -6.42M -26.92M -3.21M -2.65M 19K -30.12M -443K -31.7M 1.38M 6.14M 2.86M -8.67M -7.1M
EBIT
4.41M -9.3M -1.06M -10.89M -1.35M 19.29M 18.25M -8.58M -25.36M -6.43M -5.59M -3.47M -33.02M -2.62M -36.93M -3.67M 1.57M -1.54M -12.96M -12.2M
Depreciation & Amortization
1.91M 2.08M 2.04M 1.99M 1.75M 2.01M 1.77M 2.17M 2.18M 3.21M 2.94M 3.95M 2.9M 2.83M 5.23M 5.05M 4.57M 4.4M 4.29M 5.1M